Jm. Croffie et al., Tyrosinemia type 1 should be suspected in infants with severe coagulopathyeven in the absence of other signs of liver failure, PEDIATRICS, 103(3), 1999, pp. 675-678
Tyrosinemia type 1 is an inherited metabolic disorder attributable to defic
iency of fumarylacetoacetate hydrolase, a terminal enzyme-in the degradatio
n pathway of tyrosine. Affected individuals may present with any of a numbe
r of signs and symptoms, including failure to thrive, fever, vomiting, diar
rhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or condition
s such as rickets and hepatocellular carcinoma. If untreated, the patient m
ay die of acute liver failure before the second year of life, or from chron
ic liver failure or hepatocellular carcinoma before the end of the second d
ecade of life.(2)
Although overt liver failure with coagulopathy may be part of the presentat
ion of tyrosinemia, a significant coagulopathy in the absence of overt sign
s of liver disease has not been emphasized as a clue to the diagnosis of th
is condition. We report two tyrosinemic infants who presented with severe c
oagulopathies and no other signs of liver failure to stress this diagnostic
point.